
10,92 kr
−1,09 % i dag
Siste registrerte kurs: 13. okt., 16:26. Hentet: 14. okt., 02:26. Tid i Oslo. Kilde: Yahoo Finance. Kursene kan være forsinket.
3,18 mrd. kr
1,83 mill.
−6,12 %
Siste 12 måneder · tall i NOK
Kilde: Yahoo Finance. Ikke en anbefaling fra oss.
Circio Holding ASA er et selskap innen helse og bioteknologi notert på Oslo Børs med tickeren CRNA. Hovedkontoret ligger i Oslo, Norge. Selskapet har 10 ansatte.
Circio Holding ASA, a biotechnology company, develops novel circular RNA expression technology for gene and cell therapy. The company is developing TG01, a cancer vaccine targeting driver mutations, which is in three clinical trials for multiple myeloma, and pancreatic and lung cancer; and circVec circRNA vector platform, a modular genetic cassette for biogenesis of multifunctional circRNAs in human cells. It has a research collaboration with United Immunity Co., Ltd. for the development of vivo CAR-Macrophage (CAR-M) therapy; and Suzhou GenAssist Therapeutics Co., Ltd. to develop circVec-enhanced AAV vectors engineered for in vivo cell therapy and low dose systemic gene therapy. The company was formerly known as Targovax ASA and changed its name to Circio Holding ASA in May 2023. Circio Holding ASA was incorporated in 2010 and is based in Oslo, Norway.
Beskrivelse på engelsk fra Yahoo Finance.
Circio Holding ASA: Issuance of restricted stock units (RSUs) to the board members
Circio Holding ASA: Cancellation of Subsequent Offering
Circio Holding ASA: Registration of share capital increase following private placement of approximately NOK 200 million
Circio Holding ASA: Mandatory notification of trade (share lending in connection with private placement)
Circio Holding ASA: Ex. right to participate in potential subsequent offering today
Circio Holding ASA: Key information relating to potential subsequent offering
Circio announces that it has completed a capital raise of approx. NOK 200 million towards its in vivo CAR-T program
Circio presents strong R&D, financing and business development progress in first half year report
Circio and Full Circles Therapeutics jointly announce in vivo cell therapy research
Circio Holding ASA: Minutes from the extraordinary general meeting 25 August 2026
Siste tilgjengelige kurs for Circio Holding ASA (CRNA) er 10,92 kr, en endring på −1,09 % siste handelsdag. Kilde: Yahoo Finance. Kursene på Finansparken kan være forsinket med 15 minutter eller mer.
Circio Holding ASA er notert på Oslo Børs med tickeren CRNA. ISIN-koden er NO0013033795. Aksjen kan handles gjennom banker og nettmeglere som tilbyr handel på Oslo Børs.
Markedsverdien til Circio Holding ASA er 3,18 mrd. kr, beregnet som aksjekursen ganget med antall utestående aksjer. Det gjør selskapet til nummer 124 av 293 aksjer i Oslo målt etter markedsverdi.
Circio Holding ASA er plassert i sektoren Helse og bioteknologi (bransje: Biotechnology). På sektorsiden finner du alle aksjer i samme sektor.
Medistim ASA
MEDI · 5,21 mrd. kr
285,00 kr
+0,71 %
Nordhealth AS
NORDH · 2,21 mrd. kr
28,00 kr
0,00 %
Thor Medical ASA
TRMED · 1,84 mrd. kr
4,36 kr
−1,58 %
Photocure ASA
PHO · 1,32 mrd. kr
49,05 kr
−0,91 %
Nykode Therapeutics AS
NYKD · 1,25 mrd. kr
3,205 kr
−6,15 %
ArcticZymes Technologies ASA
AZT · 980,6 mill. kr
19,20 kr
+0,26 %